Adial Pharmaceuticals
ADIL----
Adial Pharmaceuticals (ADIL)
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Adial Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jun 15, 2026Price forecast
$7.00151.80%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy33.33%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 13 at 09:31 AM
Coastlands Capital LP reports Adial Pharmaceuticals common share purchase worth $32,613.87
- Global Report · Jul 9 at 09:02 PM
Pricing Divergence Amid Liquidity Shifts: A Microcosm of Cross-Border Risks
- Global Report · Jul 9 at 05:03 AM
The AI Hustle and Old Economy Debris: What Happens in the Market's Forgotten Corners
- Global Report · Jul 8 at 10:32 PM
US Diversified Capital Moves: Mobileye Targets Robotaxi Fleet, Adial Pharmaceuticals Secures USD 64M
- Tip Ranks · Jul 1 at 09:04 PM
Major Investor Quietly Boosts Stake in Adial Pharmaceuticals
- PUBT · Jul 1 at 09:31 AM
Coastlands Capital LP buys 25,000 Adial Pharma shares worth $65,000
